HOME > BUSINESS
BUSINESS
- Japan Approves Roche Diagnostics Test for HER2 Ultralow Breast Cancer
August 26, 2025
- Daiichi Sankyo’s TROP2 ADC Datroway Approved in China
August 26, 2025
- Austria, Germany Become First EU Markets to Launch Leqembi
August 26, 2025
- Astellas CFO Outlines Cost Cuts, Licensing Push as Xtandi Nears Patent Cliff
August 25, 2025
- Meiji’s Rezurock Approved in Thailand
August 25, 2025
- Linepharma Japan Eyes Ophthalmology as Second Pillar to Women’s Health
August 22, 2025
- Sanofi Begins Japan PII for Type 1 Diabetes Med Teplizumab
August 22, 2025
- Meiji Group Launches PII Trial of Dengue Vaccine in Thailand
August 22, 2025
- Itochu Launches J-STEP to Help Overseas Drug Makers Tackle Japan’s “Drug Loss”
August 21, 2025
- ASKA, MICIN Team Up to Develop IBS Treatment App
August 21, 2025
- AnGes Taps Boehringer for Collategene Manufacturing
August 21, 2025
- Rohto Pairs Up with Exorphia in Regenerative Medicine
August 21, 2025
- FRONTEO, Daiichi Sankyo Expand AI Collaboration into Toxicity Data Analysis
August 20, 2025
- PPIs Prescribed to 6.38 Million in July, Two APIs Control 60%: Intage
August 20, 2025
- FDA Pushes Back Decision on Hunter Syndrome Gene Therapy
August 20, 2025
- Santen Secures Asia Rights to RemeGen’s VEGF/FGF Eye Drug RC28-E
August 20, 2025
- Foreign Pharma Sales in Japan Projected to Rise 1.8% in 2025: Fuji Keizai
August 20, 2025
- Alloy Japan Looks to Turn iCAR-T into Shared Infrastructure, IND Filing Slated for 2026
August 20, 2025
- Marubeni Expands Pharma Sales Biz into Africa with Phillips Investment
August 20, 2025
- Daiichi Sankyo Snares First FDA Breakthrough Tag for ADC I-DXd
August 20, 2025
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
